Danielle Meyrick

Dr Meyrick is a practicing medical practitioner, holding an MD from the University of Western Australia and also has a PhD in radiopharmaceutical chemistry, having worked extensively in the synthesis and early clinical application of novel diagnostic and therapeutic radiopharmaceuticals.

Prior to joining Telix, Danielle held the position of Chief Scientist GenesisCare Theranostics and was instrumental in developing a Special Access clinical program and establishing a robust platform of research within the organisation. At GenesisCare, Danielle established a nuclear medicine dosimetry and central imaging service to support the Clinical CRO offering.

Danielle was previously Global Senior Innovation Technical Specialist at BASF and has held various senior positions in academia, including Deputy School Dean at the Faculty of Science and Engineering, Murdoch University, and Assoc. Professor at the School of Biomedical, Biomolecular and Chemical Sciences, University of Western Australia.